Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Antibe Therapeutics Inc(Pre-Merger)
ATBPF
Healthcare
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,...
otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:ATBPF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
...
Next
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Jul 07, 2022 4:30pm
filled at the close
as the stock drops to 60 cents. looks like about a month before the next blackout period, will management step up and support the (s.p.) or are they with the shorts and hopeing to get in cheaper
...more
(2)
•••
Doccole
X
View Profile
View Bullboard History
Comment by
Doccole
on Jul 07, 2022 11:57am
RE:20000 shares at .62
0 shares traded in USA for almost 2 days now. probably because I'm done buying. No bueno here
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Jul 07, 2022 10:48am
Just got a partial fill
@61 62 is still on the ask
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Jul 07, 2022 10:42am
summer doldrums (catch and release)
haha
(81)
•••
Stutters
X
View Profile
View Bullboard History
Post by
Stutters
on Jul 07, 2022 10:25am
20000 shares at .62
and no insider buying.
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Jul 06, 2022 8:03pm
RE: No insider buying
correction* i meant to say Q1 august /29/ 2022 Antibe Therapeutics Earnings Date & Reports FollowPortfolio
...more
(450)
•••
davgro
X
View Profile
View Bullboard History
Comment by
davgro
on Jul 06, 2022 6:09pm
RE:Q1 2023 Earnings Expected Report Date - August 20th, 2022
Link to report is below: https://drive.google.com/file/d/1jil8tHcOOedFkmt0iPLVGUJm-jBpyKQk/view?usp=sharing
(450)
•••
davgro
X
View Profile
View Bullboard History
Post by
davgro
on Jul 06, 2022 6:01pm
Q1 2023 Earnings Expected Report Date - August 20th, 2022
Today's Thomson Reuters StockReports+ for ATE has listed the next expected earnings report date (Q1 2023) as August 20th, 2022.
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Jul 06, 2022 1:23pm
No Insider Buying
aproximately another week before blackout ahead of Q1 financials. i do not expect anything new. therefore there will be no insider buying. i think management thinks they will be able to load up
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Jul 05, 2022 11:58pm
AGM ...
Annual General Meeting seems to be set for September 9, 2022. See Sedar.
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Jul 05, 2022 11:28pm
RE:Stutters
You got your hands full with that sap Forestview - best to put his tush on ignore. You'd likely have a better conversation wtih my grandmother who had Alzheimer's ... before she went 6 feet
...more
(81)
•••
Stutters
X
View Profile
View Bullboard History
Post by
Stutters
on Jul 05, 2022 10:38pm
FOREST,Mugsy is selling the same Magic Beans
(81)
•••
Stutters
X
View Profile
View Bullboard History
Comment by
Stutters
on Jul 05, 2022 6:51pm
RE:Stutters
Forestview, I have some Magic Beans for Sale. PM me if interested.
(22)
•••
Forestview
X
View Profile
View Bullboard History
Post by
Forestview
on Jul 05, 2022 5:42pm
Stutters
So, you make a comment that Paradigm doesn't own Antibe yet gives it a Buy rating. But, if they did own it, which they would have to disclose, you'd accuse it of....let me guess, pumping
...more
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Jul 05, 2022 3:54pm
Another useless post by davgro (enjoy the video)
Prev
...
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >